Investigating the role of MyD88-NF-kB signalling in regulating the inflammatory response to the emerging pre-neoplastic cells
View/ Open
Date
25/11/2019Author
Ribeiro Bravo, Isabel
Metadata
Abstract
Chronic inflammation has long been considered an enabling characteristic of
the cancer microenvironment. The release of growth and survival factors,
extracellular matrix-modifying enzymes and other bioactive molecules by
inflammatory cells into the tumour microenvironment contributes to the
acquisition of cancer hallmark capabilities. It is now known that oncogenes can
activate signals that promote the formation of an inflammatory
microenvironment, even in the absence of external stimuli, placing
inflammation as an early phenomenon in the timeline of tumour development.
The over-expression of an oncogene in pre-neoplastic cells has been shown
to promote the release of cytokines and other pro-inflammatory markers and
consequent recruitment of neutrophils and macrophages. The recruitment of
neutrophils has been previously associated with increased proliferation of
oncogene-transformed cells, however, the mechanisms by which neutrophils
exercise this trophic role are yet poorly understood.
Nuclear factor kappa B (NF-kB) transcription factors are crucial elements for
the regulation of inflammation, immune response as well as cellular stress
response. Activation of NF-kB signalling pathway leads to the expression of
mitogenic and anti-apoptotic factors, thus having the potential to promote
tumorigenesis.
MyD88 is an adaptor protein that mediates TLR/IL-1-R activation of the NF-kB
pathway. MyD88 has been shown to play both positive and negative roles in
cancer development. It is unclear however, whether the MyD88-NF-kB
signalling pathway plays a role during the earliest stages of preneoplastic
development of tumour initiation.
To better understand the role of MyD88-NF-kB in oncogene driven
inflammation during preneoplastic cell development, I was involved in the
development of a zebrafish (Danio rerio) tissue specific inducible model which
allowed the temporal control of HRasG12V oncogene expression for generation
of pre-neoplastic cells (PNCs) and the detection of the earliest signalling
events that initiate the process of tumour development. Using reporter lines,
generated elsewhere, I demonstrate the activation of MyD88-NF-kB signalling
pathway in both PNCs and recruited neutrophils. I also evaluate the effect of
its downregulation, through the expression of the murine dominant negative
mutant of IkBa, on PNCs proliferation and modulation of recruited neutrophil
behaviour.
Alongside the study of NF-kB as an inducer of tumour initiation, I also provide
evidence of heterogeneity within the neutrophil population recruited to the
PNCs and the different behaviours they exhibit.
This work demonstrates the potential of zebrafish for the study of tumour
initiation highlighting the involvement of NF-kB signalling pathway in the
establishment of an inflammatory milieu that allows the progression of this first
stage of tumorigenesis.